30 March 2007
Molecular epidemiology and characterization of resistance mechanisms to various antimicrobial agents in Acinetobacter baumannii isolated in Mérida, Venezuela
Elsa Salazar de Vegas, Beatriz Nieves, Marc Ruiz, Joaquim Ruiz, Jordi Vila, Araque María, Velázco ElsaMed Sci Monit 2007; 13(4): BR89-94 :: ID: 480240
Abstract
Background: A. Baumannii outbreaks are difficult to control because of the relative ease with which this microorganism spreads and persists in hospital settings. Successive papers reported increased resistance in clinical isolates of A. Baumannii, currently resistant to most antibiotics. The purpose of this study was to characterize the epidemiological relationship and the mechanisms of resistance to several antimicrobial agents of a collection of A. Baumannii strains. Material/Methods: Twenty A. Baumannii isolated from two intensive care units (ICUs) at the Instituto Autónomo Universitario de Los Andes, Mérida, Venezuela, were analyzed by PFGE. Characterization of resistance determinants to various antimicrobial agents was also carried out. Results: PFGE typing revealed five different patterns. Pattern 1, susceptible to ciprofloxacin and cefepime, was found to be spread among the patients of both ICUs and was also cultured from a humidifier in the neonatal ICU. All the strains were resistant to gentamicin and tetracycline, 90% to amikacin and cefotaxime, and 85% to ciprofloxacin. The resistance of the strains to ceftazidime, cefepime, and imipenem was 40, 50, and 10%, respectively. All the strains showed beta-lactamases with Ips equal to 5.4 (TEM-1) and greater than 9. Furthermore, two of them, both exhibiting resistance to imipenem, presented a beta-lactamase with an Ip of 7.2 (OXA-58). Three of seven amikacin-resistant A. Baumannii strains (PFGE-2) carried the gene encoding the APH(3')-VIa enzyme and two strains (PFGE-5) had the TET(B) determinant. Conclusions: This study shows the dissemination of A. Baumannii clinical isolates, a humidifier being the source of the strain.
Keywords: Electrophoresis, Gel, Pulsed-Field, beta-Lactamases - metabolism, Venezuela - epidemiology, Tetracyclines - pharmacology, Infant, Newborn, Imipenem - pharmacology, Gentamicins - pharmacology, Genes, Bacterial - genetics, Acinetobacter baumannii - genetics, Drug Resistance, Multiple, Bacterial, Disease Outbreaks, DNA Primers - genetics, Ciprofloxacin - pharmacology, Cephalosporins - pharmacology, Anti-Bacterial Agents - pharmacology, Acinetobacter Infections - epidemiology
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Clinical Research
Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) and 3 (TIMP-3) as New Markers of Acute Kidney Injury Afte...Med Sci Monit In Press; DOI: 10.12659/MSM.943500
12 Mar 2024 : Review article
Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive StrategiesMed Sci Monit In Press; DOI: 10.12659/MSM.943240
12 Mar 2024 : Clinical Research
Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe PsoriasisMed Sci Monit In Press; DOI: 10.12659/MSM.943360
14 Mar 2024 : Clinical Research
Renal Dysfunction Increases Risk of Adverse Cardiovascular Events in 5-Year Follow-Up Study of Intermediate...Med Sci Monit In Press; DOI: 10.12659/MSM.943956
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952